home / stock / jnj / jnj articles

JNJ Articles, Johnson & Johnson - From 04/23/24

Stock Information
Company Name: Johnson & Johnson
Stock Symbol: JNJ
Market: NYSE
Website: jnj.com
Menu
JNJ JNJ Quote JNJ Short JNJ News JNJ Articles JNJ Message Board
Get JNJ Alerts

News, Short Squeeze, Breakout and More Instantly...
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated) | Benzinga

Editor’s note: We have updated the story with Kenvue’s statement in response to the report in paragraph 7 The World Health Organiz...
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges | Benzinga

Drug shortages in the UK have more than doubled between 2020 and 2023, a recent study by the Nuffield Trust reveals. Brexit is cited as a significa...

Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert | Benzinga

The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children’s cough syrup produced by Johnson...

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies | Benzinga

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings??...
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future | Benzinga

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus...

Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results | Benzinga

Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. The company posted adjusted EPS of $2.71, up 12....

Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff | Benzinga

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates&n...

Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook | Benzinga

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the cons...

Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break | Benzinga

Earnings optimism may partly offset worries concerning rising bond yields and the volatile geopolitical situation in the Middle East, wit...
Previous 10 Next 10